Related Experiment Video

Updated: Mar 5, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

1.0K

miR-29a suppresses growth and migration of hepatocellular carcinoma by regulating CLDN1

Shaya Mahati1, Lei Xiao1, Ying Yang1

  • 1Department of Tumor Center, First Affiliated Hospital of Xinjiang Medical University (XJMU), Urumqi, 830011, China.

Biochemical and Biophysical Research Communications
|March 27, 2017
PubMed

Insights

MicroRNA-29a (miR-29a) targets claudin1 (CLDN1) in liver cancer. Suppressing CLDN1 inhibits hepatocellular carcinoma growth and migration, offering potential new therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Claudin1 (CLDN1) is crucial for cell junctions and implicated in cancer progression.
  • The specific roles and regulation of CLDN1 in hepatocellular carcinoma (HCC) remain unclear.

Purpose of the Study:

  • To investigate the biological functions and regulatory mechanisms of CLDN1 in HCC.
  • To explore the relationship between miR-29a and CLDN1 in HCC development.

Main Methods:

  • Analysis of CLDN1 and miR-29a expression in HCC tissues and cell lines.
  • Dual-luciferase reporter assays to confirm miR-29a binding to CLDN1 3'UTR.
  • In vitro and in vivo experiments involving CLDN1 knockdown and miR-29a overexpression.

Main Results:

  • Down-regulation of miR-29a and up-regulation of CLDN1 were observed in HCC.
  • An inverse correlation between miR-29a and CLDN1 expression in HCC was identified.
  • miR-29a directly targets CLDN1 via its 3'UTR.
  • CLDN1 knockdown reduced HCC cell growth and migration.
  • miR-29a overexpression suppressed tumor progression, an effect reversed by CLDN1 re-expression.

Conclusions:

  • miR-29a acts as a tumor suppressor in HCC by targeting CLDN1.
  • The miR-29a/CLDN1 axis represents a potential therapeutic target for hepatocellular carcinoma.
Keywords:
CLDN1Cell growthHepatocellular carcinoma (HCC)MigrationmiR-29a

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.6K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K